Fig. 32.1 Complexity of the inflammatory response in cardiac surgery Table 32.1 Humoral and cellular factors of the inflammatory response Humoral factors Cellular factors Contact activation products Neutrophils Factor XIIa…
Fig. 21.1 Hypothesized mechanisms of acute venous thrombosis post activation of the venous endothelium. The activation of tissue factor, P-selectin and E-selectin, platelets, inflammatory cells, and microparticles lead to thrombus…
Fig. 13.1 Critical limb ischaemia with forefoot gangrene Inflammatory markers have been evaluated among both asymptomatic [31–33] and symptomatic [31–34] subjects with PAD, however (Table 13.1). Furthermore, such markers have…
Protein Varicose veina Vein wall collagen Increased Vein wall elastin Decreased Vein wall laminin Increased Vein wall tenascin Increased Vein wall fibronectin Similar SMC collagen type I Increased SMC collagen…
Fig. 29.1 Vacuum-assisted venous drainage Advantages of Vacuum-Assisted Venous Drainage The Use of Smaller Cannulae and Shorter Tubing In several situations, such as minimally invasive surgery, repeat-cardiovascular operation, pediatric cardiac…
Resting Heart (Medtronic) MECC (Maquet) ECC.O (Sorin) ROCSafe (Terumo) CORx (CardioVention) Circuit coating Carmeda bioactive surface (with heparin) Bioline (with heparin) Prosphorylcoline Xcoating, biopassive polymer coating Not coated Centrifugal…
Fig. 28.1 Schematic illustration of the complement system and some of its inhibitors and activators. C complement, MBL mannose-binding lactin, H and I factors H and I, inhibitors of C3…
Year Author Type Configuration N Duration Patency rate Distribution Systemic anticoagulation 1971 Eger PVC tube T-shaped 36 ND ND ULAV Yes 1979 Majeski Javid Looped 2 210 min 100 %…
Biomaterial-dependent factorsa Type of extracorporeal circuit Type of oxygenator and pump Biomaterial-independent factors Extracorporeal perfusion factors Composition of the priming solution Cardioplegia Pulsatile or non-pulsatile perfusion Temperature during CPB Preoperative…
Intervention Study type Technical success (%) Amputation free (%) Survival (%) Primary patency (%) Secondary patency (%) Time to f/u (months) PTA Meta-analysis 95.8 93.4 98.3 77.4 83.3 1 82.4…
